Abstract
Objective: To establish a suspension array-based analysis system for determining mitochondrial haplogroups, using DNA purified from formalin-fixed paraffin-embedded (FFPE) autopsy tissues. Background Because the evolutionary rate of mitochondrial DNA (mtDNA) is much higher than that of nuclear DNA, and because mtDNA is highly polymorphic, mitochondrial single nucleotide polymorphisms (mtSNPs) are expected to contribute more extensively to the functional differences among individuals than those SNPs in the nuclear DNA. Design/Methods: We carefully purified total DNA from FFPE autopsy tissues by using ethanol precipitation. By using our system, we could estimate 7 major mitochondrial haplogroups for Japanese (A, D, D4, D5, F, G1, and G2) containing 17 subhaplogroups (B4b, B4c, B5, D4a, D4b1b, D4b2a, D4b2b, D4d1b, D4e1, D4e2, D4g, D4h, M7a, M7b, M10, N9a, and N9b) belonging to 2 super haplogroups (M and N), based on information obtained from the comprehensive analysis of mtSNPs in the coding region of mtDNA. We first tested approximately 100 DNA samples from blood and FFPE tissues of autopsy subjects whose haplogroups had been identified by DNA analysis of frozen-kidney tissues. To examine more fully the utility of the system, we analyzed 5,161 DNA samples from FFPE tissues. Results: We could analyze 4,485 (87%) of them successfully. However, we could not analyze the remainder (13%) because of an insufficient PCR amplification due to severe DNA fragmentation. We had previously revealed the haplogroup frequencies of 1,500 frozen-kidney DNA samples. In comparison, the haplogroup D4a was overestimated, but the haplogroups M7a, D4b1b and N9b were underestimated, by the present system we developed. Conclusions: We have established a method to purify DNA from FFPE tissues and developed a suspension array-based analytic system to estimate major haplogroups of Japanese individuals. We believe that our system for the classification of mitochondrial haplogroups will be very helpful not only for pathogenetical studies, but also for epidemiological cohort studies. Supported by: In part by grants from the program Grants-in-Aid for Scientific Research (C) [18590317, and 21590411]; by Grant 20B-13 from the program Research Grants for Nervous and Mental Disorders of the Ministry of Health, Labour, and Welfare; and by grants for scientific research from the Takeda Science Foundation, and Sankyo Foundation of Life Science. Disclosure: Dr. Nishigaki has nothing to disclose. Dr. Hosoya has nothing to disclose. Dr. Naka-Mieno has nothing to disclose. Dr. Arai has nothing to disclose. Dr. Sawabe has nothing to disclose. Dr. Tanaka has nothing to disclose.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
